Repaglinide Teva

Medicinal product

(Invented) name

Repaglinide Teva

Active substance (s)

Repaglinidas

Strength

1 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BX02, Repaglinide

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2009-06-29

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tablet	1 vnt.
Repaglinidas	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
37034	50653	1050653	lizdinė plokštelė	N30		Receptinis	EU/1/09/530/006	Netiekiama	-	-	No	-	-
37035	50654	1050654	lizdinė plokštelė	N90		Receptinis	EU/1/09/530/007	Netiekiama	-	-	No	-	-
37036	50655	1050655	lizdinė plokštelė	N120		Receptinis	EU/1/09/530/008	Netiekiama	-	-	No	-	-
37037	50656	1050656	lizdinė plokštelė	N270		Receptinis	EU/1/09/530/009	Netiekiama	-	-	No	-	-
37038	50657	1050657	lizdinė plokštelė	N360		Receptinis	EU/1/09/530/010	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-06-29	Registruotas